Device Week, 25 February 2022 – CardioMEMS, G7 Data, And Investment Outlook
Executive Summary
In this edition of Device Week, Medtech Insight’s Reed Miller chats with UK-based reporter Barnaby Pickering about Abbott’s recent supplementary premarket submission to its CardioMEMS platform, recent safety data for Dexcom’s G7 continuous glucose monitor, and where KPMG expects life sciences investment to be focused in 2022.
Listen to the podcast via the player below:
The archive of Medtech Insight’s Device Week, Digital Health Roundups, Speaking of Medtech and the rest of Informa Pharma Intelligence’s podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, Tune In, and Spotify Podcasts.
Medtech Insight articles addressing topics discussed in this episode: